A Phase 1b/2a Study To Evaluate The Safety Of CMTX-101 In Combination With Inhaled Tobramycin In People With Cystic Fibrosis Chronically Infected With Pseudomonas Aeruginosa

Conditions: Persistent Infection; Cystic Fibrosis Interventions: Drug: CMTX-101; Drug: Placebo Sponsors: Clarametyx Biosciences, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials